Biomarker Assays

Solutions

  • Qualified biomarker method list
  • Custom reagent generation
  • De novo biomarker method development
  • Ultrasensitive nanoparticle enabled immunoPCR platform – AmplattoTM
  • Multiplex biomarker assays

Success = Access to large number of fit-for-purpose validated methods + Ability to generate quality reagents + Ultra-sensitive technology platform

Biomarker analyses are becoming increasingly important in pre-clinical and clinical trials to understand the biological activity, safety, and efficacy profile of candidate therapeutics.

Somru BioScience has more than 70 methods available to our clients. We continue to add more methods to our list. Very often the development of bioanalytical methods for a novel biomarker is stalled due to lack of quality and specific reagents. Scientists at Somru have significant experience in not only developing robust bioanalytical assays for biomarkers but also have experience in generating quality reagents.

Accurate detection of specific protein biomarkers is crucial for the diagnosis of disease, monitoring drug therapy, and patient screening. Immunoassays have been the method of choice for protein analyte measurements for more than four decades. However, the current immunoassay technologies lack sufficient sensitivity to measure proteins at sub-picomolar level. There is an increasing demand for immunoassays that can detect sub-fM (femtomolar) to aM (attomolar) level of proteins to support early detection of diseases.

 

Unleashing the power of Amplatto™ technology to achieve attomolar level of analyte detection

Learn.
Engage.
Connect.

Learn | Engage | Connect

Read news, updates, and transforming technologies of drug development

Ready to get started?

Consult with a Scientist today!